Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
Clinical trial NCT03610321 · UNKNOWN
Trial details
- NCT number
- NCT03610321
- Sponsor
- First Affiliated Hospital of Harbin Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-09-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.